Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves.
about
Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification.Calcific aortic valve stenosis: methods, models, and mechanismsEx vivo evidence for the contribution of hemodynamic shear stress abnormalities to the early pathogenesis of calcific bicuspid aortic valve disease.ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model.Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.Aortic valve: mechanical environment and mechanobiology.Potential drug targets for calcific aortic valve disease.Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease.Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly.Innate and Adaptive Immunity in Calcific Aortic Valve DiseaseCellular Changes during Renal Failure-Induced Inflammatory Aortic Valve Disease.Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction.Endothelial cells and cathepsins: Biochemical and biomechanical regulation.Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: a randomized population-based study.Prevention of calcific aortic valve stenosis-fact or fiction?Calcific aortic stenosis: lessons learned from experimental and clinical studies.A genome-wide association study of congenital cardiovascular left-sided lesions shows association with a locus on chromosome 20.Iron alters valvular interstitial cell function and is associated with calcification in aortic stenosis.Aortic valve disease: preventable or inevitable?New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review.Pathophysiologic mechanisms of calcific aortic stenosis.Cysteine cathepsins and their potential in clinical therapy and biomarker discovery.Cells and extracellular matrix interplay in cardiac valve disease: because age matters.Pathophysiology of Aortic Stenosis and Mitral Regurgitation.MicroRNA-125b and chemokine CCL4 expression are associated with calcific aortic valve disease.Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.Less fibrosis in elderly subjects supplemented with selenium and coenzyme Q10-A mechanism behind reduced cardiovascular mortality?Long-term endurance training increases serum cathepsin S and decreases IL-6 and hsCRP levels.Interaction between Human Cathepsins K, L, and S and Elastins
P2860
Q30474772-95AA73B4-9DC2-43E0-B8D5-879B0A924551Q30503246-13CD3C7C-C856-46D6-A925-D2357BB3B4EBQ31106131-CA6FCE5A-041E-440C-9C79-44E4F354392CQ33414426-F63B8B48-0101-4256-B4A2-51BC70A62BBEQ33589249-F1128714-13D4-4429-A072-61A3F38110E1Q33767188-482EE6E0-0821-4C3E-85C9-77A1DF9A8673Q34399089-1E09C146-E679-4FE2-B301-8341ADAADBD2Q35078393-B8013763-470B-4858-9133-6C1EF7866DCAQ35116249-7E6CAE9A-6E2F-4609-829A-5C97103308C8Q35612638-55856FE7-DE7D-4E12-A7C3-5062D8815C12Q35662347-A2344B30-E731-455C-AD27-25E83902C83FQ36560578-0E8C5E7A-EF22-4F63-9CDC-65780E82B539Q36563605-6F64A599-BBC7-4AFD-98D9-01967BC9663DQ37118040-E00EC93F-1093-4D05-9C22-5619C8E51531Q37249445-1AE900EA-8DDC-4A87-9C8F-229E500D33D4Q37331207-0DF7A14A-331B-4FD3-B93B-0CA4CAE9701AQ37367970-7BFBA3CC-860F-4B37-8CCB-B73F9A58ED61Q37562904-A743EB46-61A3-499F-9F91-E176A13CFFE1Q37818210-1DB32674-3FD0-47E4-9D9B-4644D521204AQ37950408-9DFED426-6C66-4A0F-864A-4CA3050089D0Q37987807-B7F0327F-C058-4E66-A0E4-8589C48A9DEDQ38182521-3BCCEF55-A169-4A43-9674-480D74C168E1Q38718100-9A2099B0-47CD-4587-8E55-C1E811070B78Q39390979-BED5575C-2A9A-4E09-88FD-DA7B583BCE57Q40704567-4AD14155-F00B-4F0A-A0A9-934412F19D80Q41999917-7AADA5D3-7D9A-4CEE-9132-53BC45F9B27FQ47582008-625111BD-B2BD-407C-A6E3-442ADAD78F24Q51321008-A641A652-FB6C-4B88-A243-BA277103BF4EQ57696089-5717EF06-6195-46F9-8A1B-3C1DC9347D6B
P2860
Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Increased expression of elasto ...... n C in stenotic aortic valves.
@en
Increased expression of elasto ...... n C in stenotic aortic valves.
@nl
type
label
Increased expression of elasto ...... n C in stenotic aortic valves.
@en
Increased expression of elasto ...... n C in stenotic aortic valves.
@nl
prefLabel
Increased expression of elasto ...... n C in stenotic aortic valves.
@en
Increased expression of elasto ...... n C in stenotic aortic valves.
@nl
P2093
P50
P1476
Increased expression of elasto ...... in C in stenotic aortic valves
@en
P2093
Heikki Turto
Jani Lappalainen
Jyri Lommi
Kalervo Werkkala
Ken A Lindstedt
Markku Kupari
Petri T Kovanen
Satu Helske
P304
P356
10.1161/01.ATV.0000228824.01604.63
P407
P577
2006-05-25T00:00:00Z